Digital diet program aims to remit diabetes in 64 patients
NCT ID NCT04663061
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study tested whether a high-intensity medical weight loss program, supported by a digital platform and continuous glucose monitors, could help people with type 2 diabetes lose weight and achieve remission. 64 participants were enrolled and compared to a group receiving standard diabetes education. The goal was 15% weight loss and an A1c below 6.5% without diabetes medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intensive medical weight loss program (diet, exercise, counseling) plus continuous glucose monitoring and digital support
What this could lead to
If successful, this approach could offer a scalable way to help many people with type 2 diabetes achieve remission without long-term medication.
What could go wrong
This is a small, completed trial (64 participants) with no phase designation, so results may not apply broadly. Weight loss is difficult to maintain, and remission may not be permanent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Wake Forest Univesity Health Sciences
Winston-Salem, North Carolina, 27157, United States